APA 6th Edition

Debeljak, T. i KoresPlesničar, B. (2021). DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT. Psychiatria Danubina, 33 (suppl 2), 162-162. Preuzeto s https://hrcak.srce.hr/index.php/270017

---

MLA 8th Edition

Debeljak, Tana i Blanka KoresPlesničar. "DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT." Psychiatria Danubina, vol. 33, br. suppl 2, 2021, str. 162-162. https://hrcak.srce.hr/index.php/270017. Citirano 01.05.2024.

---

Chicago 17th Edition

Debeljak, Tana i Blanka KoresPlesničar. "DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT." Psychiatria Danubina 33, br. suppl 2 (2021): 162-162. https://hrcak.srce.hr/index.php/270017

---

Harvard

Debeljak, T., i KoresPlesničar, B. (2021). 'DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT', Psychiatria Danubina, 33(suppl 2), str. 162-162. Preuzeto s: https://hrcak.srce.hr/index.php/270017 (Datum pristupa: 01.05.2024.)

---

Vancouver

Debeljak T, KoresPlesničar B. DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT. Psychiatria Danubina [Internet]. 2021 [pristupljeno 01.05.2024.];33(suppl 2):162-162. Dostupno na: https://hrcak.srce.hr/index.php/270017

---

IEEE

T. Debeljak i B. KoresPlesničar, "DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT", Psychiatria Danubina, vol.33, br. suppl 2, str. 162-162, 2021. [Online]. Dostupno na: https://hrcak.srce.hr/index.php/270017. [Citirano: 01.05.2024.]